Loading
Total declarations
Companies
▲ Purchases (55 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Filing timeline
BuySaleColumn Group L P
Insider track record
Disclosed buys
55
Disclosed sells
0
Signal history
Closed purchases
Market purchases
55
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Column Group L P: trading record in brief
Column Group L P has filed trades across 3 companies (mainly through SEC (Form 4)), most often in NGM Biopharmaceuticals Inc, Constellation Pharmaceuticals Inc and Nurix Therapeutics, Inc. In total, 60 filings cover trades dated from 14 December 2020 to 5 April 2024.
No open-market sale appears; the market trades are 55 purchases worth €39.6M. The amount is not disclosed for 4 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants.
Half of the purchases are above €243k and half below. Of 24 purchases, 22 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 8 April 2024, reports a transaction in NGM Biopharmaceuticals Inc. The most recent open-market purchase was published on 17 November 2023, 1,072 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Column Group L P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
949,862 sharesCommon StockSEC:0000950142-24-001000:0
16,791 shares@ US$0.70750.1% of flowCommon StockSEC:0000950170-23-064847:0
Canonical exit: 13 Feb 2024 (T+90)
7,542 shares@ US$4.99960.2% of flowCommon StockSEC:0000899243-23-003137:0
Canonical exit: 30 Apr 2023 (T+90)
9,900 shares@ US$4.99940.2% of flowCommon StockSEC:0000899243-23-002630:0
Canonical exit: 23 Apr 2023 (T+90)
37,639 shares@ US$4.99760.9% of flowCommon StockSEC:0000899243-23-002380:0
Canonical exit: 19 Apr 2023 (T+90)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001855:0
Canonical exit: 12 Apr 2023 (T+90)
100,070 shares@ US$4.84182.4% of flowCommon StockSEC:0000899243-23-001694:0
Canonical exit: 10 Apr 2023 (T+90)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038468:0
Canonical exit: 12 Mar 2023 (T+90)
35,997 shares@ US$4.99880.9% of flowCommon StockSEC:0000899243-22-036916:0
Canonical exit: 19 Feb 2023 (T+90)
104,090 shares@ US$4.98712.8% of flowCommon StockSEC:0000899243-22-035277:0
Canonical exit: 1 Feb 2023 (T+90)
76,877 shares@ US$4.86022.0% of flowCommon StockSEC:0000899243-22-034562:0
Canonical exit: 25 Jan 2023 (T+90)
51,046 shares@ US$4.74841.3% of flowCommon StockSEC:0000899243-22-034352:0
Canonical exit: 23 Jan 2023 (T+90)
951,684 shares@ US$13.5064.4% of flowCommon StockSEC:0000899243-22-022212:0
Canonical exit: 7 Sept 2022 (T+90)
33,071 shares@ US$13.03332.1% of flowCommon StockSEC:0000899243-22-021215:0
Canonical exit: 31 Aug 2022 (T+90)
59,766 shares@ US$13.46584.0% of flowCommon StockSEC:0000899243-22-020688:0
Canonical exit: 29 Aug 2022 (T+90)
19,534 shares@ US$13.49351.3% of flowCommon StockSEC:0000899243-22-020202:0
Canonical exit: 24 Aug 2022 (T+90)
17,240 shares@ US$13.3681.1% of flowCommon StockSEC:0000899243-22-019689:0
Canonical exit: 22 Aug 2022 (T+90)
19,984 shares@ US$13.25471.3% of flowCommon StockSEC:0000899243-22-019209:0
Canonical exit: 17 Aug 2022 (T+90)
86,110 shares@ US$13.41715.8% of flowCommon StockSEC:0000899243-22-018849:0
Canonical exit: 15 Aug 2022 (T+90)
125,096 sharesCommon StockSEC:0000899243-22-018401:0
Canonical exit: 11 Aug 2022 (T+90)
125,096 sharesCommon StockSEC:0000899243-22-018399:0
Canonical exit: 11 Aug 2022 (T+90)
77,866 shares@ US$11.22584.4% of flowCommon StockSEC:0000899243-22-018031:0
Canonical exit: 9 Aug 2022 (T+90)
80,430 shares@ US$10.79294.4% of flowCommon StockSEC:0000899243-22-017672:0
Canonical exit: 7 Aug 2022 (T+90)
241,750 sharesCommon StockSEC:0000899243-22-003320:0
Canonical exit: 24 Apr 2022 (T+90)
241,750 sharesCommon StockSEC:0000899243-22-003318:0
Canonical exit: 24 Apr 2022 (T+90)
25 of 24 declarations
